431
Views
23
CrossRef citations to date
0
Altmetric
Review

Immunotherapy for Medulloblastoma: Current Perspectives

, , &
Pages 57-77 | Published online: 20 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ludovica Lospinoso Severini, Francesca Ghirga, Francesca Bufalieri, Deborah Quaglio, Paola Infante & Lucia Di Marcotullio. (2020) The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma. Expert Opinion on Therapeutic Targets 24:11, pages 1159-1181.
Read now

Articles from other publishers (22)

Tristan E. Knight, Kwang Woo Ahn, Kyle M. Hebert, Rasha Atshan, Donna A. Wall, Kanhatai Chiengthong, Seth J. Rotz, Ellen Fraint, Hemalatha G. Rangarajan, Jeffery J. Auletta, Akshay Sharma, Carrie L. Kitko, Hasan Hashem, Kirsten M. Williams, Baldeep Wirk, Christopher C. Dvorak, Kasiani C. Myers, Michael A. Pulsipher, Anne B. Warwick, Nahal Rose Lalefar, Kirk R. Schultz, Muna Qayed, Larisa Broglie, Mary Eapen & Gregory A. Yanik. (2023) Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. Transplantation and Cellular Therapy 29:6, pages 380.e1-380.e9.
Crossref
Jawad Fares, Zachary B. Davis, Julian S. Rechberger, Stephanie A. Toll, Jonathan D. Schwartz, David J. Daniels, Jeffrey S. Miller & Soumen Khatua. (2023) Advances in NK cell therapy for brain tumors. npj Precision Oncology 7:1.
Crossref
Rui Ferreira Marques, Daniel Antunes Moreno, Luciane da Silva, Leticia Ferro Leal, Flávia Escremim de Paula, Iara Santana, Gustavo Teixeira, Fabiano Saggioro, Luciano Neder, Carlos Almeida Junior, Bruna Mançano & Rui Manuel Reis. (2023) Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Frontiers in Immunology 14.
Crossref
Jung Yoon Choi. (2023) Medulloblastoma: Current Perspectives and Recent Advances. Brain Tumor Research and Treatment 11:1, pages 28.
Crossref
Margot A. Lazow, Joshua D. Palmer, Maryam Fouladi & Ralph Salloum. (2022) Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics 19:6, pages 1733-1751.
Crossref
Paula Martín-Rubio, Pilar Espiau-Romera, Alba Royo-García, Laia Caja & Patricia Sancho. (2022) Metabolic determinants of stemness in medulloblastoma. World Journal of Stem Cells 14:8, pages 587-598.
Crossref
Ariana Pritha, Richard Anderson, David E Anderson & Theodore Nicolaides. (2022) A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma. Cureus.
Crossref
Zahra Abbas, Courtney George, Mathew Ancliffe, Meegan Howlett, Anya C. Jones, Mani Kuchibhotla, Robert J. Wechsler-Reya, Nicholas G. Gottardo & Raelene Endersby. (2022) Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets. Frontiers in Immunology 13.
Crossref
Qiyue Wang & Ji Liu. (2022) Medulloblastoma: Immune microenvironment and targeted nano-therapy. OpenNano 6, pages 100035.
Crossref
David R. Ghasemi, Gudrun Fleischhack, Till Milde & Kristian W. Pajtler. (2022) The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma. Cancers 14:3, pages 679.
Crossref
Ian Burns, William D. Gwynne, Yujin Suk, Stefan Custers, Iqra Chaudhry, Chitra Venugopal & Sheila K. Singh. (2022) The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues. Frontiers in Oncology 12.
Crossref
Lakshana Sreenivasan, Ling Vicky Li, Pascal Leclair & Chinten James Lim. (2022) Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells. Cells 11:3, pages 381.
Crossref
Jean-Paul Bryant & Toba N. Niazi. 2022. Pediatric Neurosurgery for Clinicians. Pediatric Neurosurgery for Clinicians 249 271 .
Yujin Suk, William D. Gwynne, Ian Burns, Chitra Venugopal & Sheila K. Singh. 2022. Medulloblastoma. Medulloblastoma 1 12 .
Mohammadmahdi Sabahi, Sara Hanaei & Nima Rezaei. 2022.
Rebecca M. Hill, Sabine L. A. Plasschaert, Beate Timmermann, Christelle Dufour, Kristian Aquilina, Shivaram Avula, Laura Donovan, Maarten Lequin, Torsten Pietsch, Ulrich Thomale, Stephan Tippelt, Pieter Wesseling, Stefan Rutkowski, Steven C. Clifford, Stefan M. Pfister, Simon Bailey & Gudrun Fleischhack. (2021) Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. Cancers 14:1, pages 126.
Crossref
Claudia Paret, Nadine Lehmann, Hannah Bender, Maximilian Sprang, Clemens J. Sommer, Denis Cana, Larissa Seidmann, Arthur Wingerter, Marie A. Neu, Khalifa El Malki, Francesca Alt, Lea Roth, Federico Marini, Malte Ottenhausen, Martin Glaser, Markus Knuf, Alexandra Russo & Joerg Faber. (2021) Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1. Cancers 13:22, pages 5838.
Crossref
Silpa Gampala & Jer-Yen Yang. (2021) Hedgehog Pathway Inhibitors against Tumor Microenvironment. Cells 10:11, pages 3135.
Crossref
Marije J. Voskamp, Shuang Li, Kim R. van Daalen, Sandra Crnko, Toine ten Broeke & Niels Bovenschen. (2021) Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives. Cancers 13:21, pages 5387.
Crossref
Jawad Fares, Sumit Gupta, Vidya Gopalakrishnan & Soumen Khatua. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy 477 502 .
Nazanin K. Majd, Pushan R. Dasgupta & John F. de Groot. 2021. Immunotherapy. Immunotherapy 233 258 .
Roberto Carta, Giada Del Baldo, Evelina Miele, Agnese Po, Zein Mersini Besharat, Francesca Nazio, Giovanna Stefania Colafati, Eleonora Piccirilli, Emanuele Agolini, Martina Rinelli, Mariachiara Lodi, Antonella Cacchione, Andrea Carai, Luigi Boccuto, Elisabetta Ferretti, Franco Locatelli & Angela Mastronuzzi. (2020) Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era. Frontiers in Oncology 10.
Crossref